Squarepoint’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.78M Buy
119,978
+46,711
+64% +$1.47M ﹤0.01% 902
2025
Q1
$2.4M Buy
73,267
+52,775
+258% +$1.73M ﹤0.01% 1079
2024
Q4
$741K Sell
20,492
-475
-2% -$17.2K ﹤0.01% 1711
2024
Q3
$654K Buy
+20,967
New +$654K ﹤0.01% 1638
2023
Q4
Sell
-14,551
Closed -$401K 2952
2023
Q3
$401K Sell
14,551
-1,104
-7% -$30.4K ﹤0.01% 1750
2023
Q2
$471K Buy
15,655
+3,199
+26% +$96.2K ﹤0.01% 1622
2023
Q1
$451K Sell
12,456
-19,888
-61% -$721K ﹤0.01% 1513
2022
Q4
$1.15M Sell
32,344
-8,498
-21% -$303K ﹤0.01% 1033
2022
Q3
$1.38M Buy
+40,842
New +$1.38M 0.01% 939
2022
Q2
Sell
-13,785
Closed -$446K 2614
2022
Q1
$446K Sell
13,785
-20,307
-60% -$657K ﹤0.01% 1547
2021
Q4
$994K Buy
+34,092
New +$994K ﹤0.01% 1223
2021
Q2
Sell
-22,764
Closed -$596K 3015
2021
Q1
$596K Buy
22,764
+8,709
+62% +$228K ﹤0.01% 1411
2020
Q4
$354K Sell
14,055
-23,132
-62% -$583K ﹤0.01% 1748
2020
Q3
$775K Sell
37,187
-24,544
-40% -$512K 0.01% 1077
2020
Q2
$1.47M Buy
61,731
+1,623
+3% +$38.5K 0.02% 750
2020
Q1
$1.08M Sell
60,108
-28,923
-32% -$520K 0.03% 687
2019
Q4
$2.11M Buy
89,031
+39,579
+80% +$939K 0.01% 853
2019
Q3
$1.36M Buy
49,452
+37,928
+329% +$1.04M 0.01% 1000
2019
Q2
$381K Sell
11,524
-50,621
-81% -$1.67M ﹤0.01% 1770
2019
Q1
$2.18M Buy
62,145
+43,843
+240% +$1.54M 0.02% 738
2018
Q4
$608K Buy
18,302
+866
+5% +$28.8K 0.01% 1139
2018
Q3
$878K Buy
+17,436
New +$878K 0.01% 1052
2018
Q2
Sell
-56,569
Closed -$2.59M 2031
2018
Q1
$2.59M Buy
56,569
+47,122
+499% +$2.16M 0.04% 486
2017
Q4
$376K Sell
9,447
-42,729
-82% -$1.7M 0.01% 1354
2017
Q3
$2.09M Buy
52,176
+5,869
+13% +$235K 0.04% 478
2017
Q2
$2M Buy
46,307
+3,156
+7% +$136K 0.04% 512
2017
Q1
$1.35M Buy
43,151
+10,065
+30% +$315K 0.04% 492
2016
Q4
$835K Buy
+33,086
New +$835K 0.03% 577
2016
Q3
Sell
-11,861
Closed -$242K 1246
2016
Q2
$242K Sell
11,861
-13,133
-53% -$268K 0.02% 824
2016
Q1
$381K Sell
24,994
-3,500
-12% -$53.4K 0.03% 731
2015
Q4
$383K Buy
+28,494
New +$383K 0.04% 678